Collaboration aims to accelerate drug discovery and advance company’s tRNA synthetase platformSAN DIEGO, Oct. 11, 2022 (GLOBE NEWSWIRE) -- aTyr...
BOTHELL, Wash., Oct. 11, 2022 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) announces the selection of its novel, broad-spectrum...
BOSTON, Oct. 11, 2022 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage biopharmaceutical company developing proprietary antibody-based therapeutics...
VANCOUVER, British Columbia, Oct. 11, 2022 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the “Company” or “AVCR”) is pleased...
UAMS Exterior UAMS hospital exterior The partnership is the first-of-its-kind in the region and creates a new care at home option...
BELGRADE, Mont., Oct. 11, 2022 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company...
BURLINGTON, Mass. and JERUSALEM, Oct. 11, 2022 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”),...
TORONTO, Oct. 11, 2022 (GLOBE NEWSWIRE) -- VITALHUB CORP. (TSX: VHI) (the “Company” or “VitalHub”) is pleased to announce today...
Multi-year strategic research and commercial collaboration agreement aims to significantly impact preventative care and underscores Company’s commitment to women’s healthNASHUA,...
VANCOUVER, British Columbia and CARLSBAD, Calif., Oct. 11, 2022 (GLOBE NEWSWIRE) -- Canary Medical, a medical data company focused on...
- BBP-398, an investigational SHP2 inhibitor, is a potentially optimal agent for use in combination therapies given its continuous, once-daily...
TORONTO, Oct. 11, 2022 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical...
VANCOUVER, British Columbia, Oct. 11, 2022 (GLOBE NEWSWIRE) -- CloudMD Software & Services Inc. (TSXV: DOC, OTCQX: DOCRF, Frankfurt: 6PH)...
Sale Reduces Cash Burn, Includes Seven-Year Earn-Out Provision;Third Quarter Revenue Expected to be Approximately $2.5 Million; Active Customer Sites Increase...
US Insurance Award Recognizes Their Innovative Solution for Managing Return-to-Work and Temporary Total DisabilityFORT WORTH, Texas, Oct. 11, 2022 (GLOBE...
- Company to showcase products including recently FDA cleared SiLO TFXTM at booth #4604 – CARLSBAD, Calif., Oct. 11, 2022...
Eight Posters Highlighting Pre-Clinical Programs and Leading Gene Therapy Manufacturing and Administration CapabilitiesLEXINGTON, Mass. and AMSTERDAM, the Netherlands, Oct. 11,...
Collaboration Streamlines Clinical Trial Tokenization, Further Empowers Medical Affairs, Market Access, HEOR and Commercial Analytics for ClientsMORRISVILLE, N.C., Oct. 11, 2022...
NMD Pharma Reports Positive Top-Line Data from a Phase I/IIa Clinical Trial of NMD670 in Patients with Myasthenia Gravis Data...
Arecor Therapeutics plc(“Arecor”, the “Company” or the “Group”) HEADLINE RESULTS FROM PHASE I CLINICAL TRIAL OF ULTRA-RAPID ACTING INSULIN CANDIDATE...